American Association for Cancer Research Scientist-Survivor Program was founded
In 1999, American Association for Cancer Research (AACR) Scientist-Survivor Program which united researchers with patients and survivor advocates…
In 1999, American Association for Cancer Research (AACR) Scientist-Survivor Program which united researchers with patients and survivor advocates…
In 1999, ClinicalTrials.gov was founded as an Internet-based resource that provide information about clinical research studies to the…
In 1999, the Vancouver Prostate Centre received a $20 million donation by Vancouver businessman Jim Pattison, the largest…
In 1999, Michael Smith, recipient of the 1993 Nobel Prize in Chemistry, founded Canada’s Michael Smith Genome Science…
In 1999, University of California at San Francisco Cancer Research Institute received NCI Comprehensive Cancer Center designation. The…
On Oct. 30, 1999, Livermore National Lab work completed work on the mouse genome as part of Laboratory…
In 1999, Dr. Emil Kakkis at Los Angeles Biomedical Research Institute (LA BioMed) developed Enzyme Replacement Therapy to…
On Dec. 22, 1998, Washington University – St. Louis researcher Jeffrey I. Gordon, MD and colleagues developed a…
Dec. 22, 1998, researchers from Barnes-Jewish Hospital in St. Louis announced using a revolutionary system that uses superconducting…
On Oct. 30, 1998, Peter Eriksson of the Salk Institute and Fred Gage of the Sahlgrenska University Hospital…
On Oct. 12, 1998, Louis J. Ignarro of the University of California School of Medicine was awarded the…
In Oct. 1998, the Fetal Alcohol Syndrome Surveillance Network was created to determine the prevalence of FAS within…
On Sept. 25, 1998, the U.S. Food and Drug Administration (FDA) approved the monoclonal antibody Herceptin (Trastuzumab) for…
On Sept. 14, 1998, researchers from the Breast Cancer Prevention Trial (BCPT) published a full report and update…
On Jul. 29, 1998, the Stamp Out Breast Cancer stamp was first issued. The driving force behind the…
On Jul. 15, 1998, Aptein, founded by Glenn Kawasaki in Seattle, was acquired by Cambridge Antibody Technology (CAT)…
On Jun. 16, 1998, University of Washington Medicine, Fred Hutchinson Cancer Research Center and Seattle Children’s announced the…
On April 30, 1998, the U.S. Food and Drug Administration (FDA) approved the Genentech’s drug Xeloda (capecitabine) for…
On Mar. 27, 1998. the Pfizer drug Viagra (Sildenafil) was approved by the U.S. Food and Drug Administration…
In March 1998, the Stop TB Initiative was established following a meeting of the First Ad hoc Committee…
On Feb. 10, 1998, the Cook County Board of Commissioners took the final steps in the approval process,…
On Jan. 13, 1998, Seattle Genetics (Seagen) was founded in Bothell as a biotechnology company focused on developing…
In 1998, The Norris Comprehensive Cancer Center received a $5 million gift from local philanthropist Henrietta Lee which…
In 1998, The Mark O. Hatfield Research Center was dedicated. The center houses a variety of basic and…
In 1998, University of Calgary’s Dr. Patrick Lee revealed that reovirus injected in mice shrank tumours from brain…
On Nov. 10, 1998, Immunex announced that ENBREL(tm) (etanercept) had received approval from the U.S. Food and Drug…
In 1998, Cancer incidence rates showed first sustained decline since the National Cancer Institute (NCI) began keeping records…
In 1998, Immunex dedicated its new manufacturing and development center. The 100,000 square foot complex broke ground in…
In 1998, the first phase to consolidate U.S. Food and Drug Administration (FDA) laboratories nationwide from 19 facilities…
In 1998, the Pediatric Rule was implemented that required drug manufacturers to study the efficacy and safety of…